| abstract |
Certain 3-phenyl-2-arylalkylthiopropionic acid derivatives useful for the treatment of clinical conditions such as fatty disease (dyslipidemia), whether related to insulin resistance and other metabolic syndrome symptoms Enzymatic and chemical production methods are described, as well as certain novel intermediates used in these methods. |